<?xml version="1.0" encoding="UTF-8"?>
<p>Despite positive results, recent studies have indicated that reactive oxygen species (ROS) scavenging in cancer cells, particularly during chemotherapy, interferes with the primary mechanism, which triggers apoptosis in these cells. In this way, antioxidant supplementation is a double-edged sword. To be used as a supportive therapy during cancer treatments, it might take into account the type of cancer, general patient status, and antioxidant dosage and type to reach the best performance. Another suggestion is to administer a single antioxidant prescribed by a unique kind of cancer, since antioxidants, as mentioned previously, can play synergic or antagonistic effects and even lead to uncontrollable effects in the human body when administrated as a non-controlled combination [
 <xref rid="B96-ijms-22-00265" ref-type="bibr">96</xref>].
</p>
